ArticleFrontiers in oncology2022

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas.

Qijun Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.